Feb 20, 2018 by Brian FeroldiIQVIA Holdings Ends 2017 Strong, Shares Bullish GuidanceThe leading provider of services and data for the life sciences industry posted double-digit gains in revenue and profits.
Feb 20, 2018 by Brian FeroldiMazor Robotics Flips to ProfitabilityHigher revenue and falling costs combined to swing Mazor's bottom-line into the black.
Feb 20, 2018 by Brian FeroldiAlkermes Sets Itself Up for a "Transformative" 2018The commercial-stage biopharma caps off 2017 on a high note and prescribes itself a healthy future.
Feb 18, 2018 by Brian Feroldi, Keith Speights, and Chuck Saletta3 Top Biotech Stocks to Buy in FebruaryWant to cash in on the life sciences boom? Here are three stocks to check out.
Feb 17, 2018 by Brian Feroldi, Dan Caplinger, and Brian Stoffel3 Growth Stocks to Buy and Hold for the Next 50 YearsLooking for a few companies that you can safely own for the ultra-long term? Start with these three.
Feb 15, 2018 by Brian FeroldiWhy AMAG Pharmaceuticals, Inc. and Antares Pharma, Inc. Are Soaring TodayFavorable regulatory news causes traders to cheer.
Feb 14, 2018 by Brian FeroldiHere's Why Alkermes Spiked TodayExpectation-topping results mixed with upbeat guidance put Wall Street in a good mood.
Feb 14, 2018 by Brian FeroldiHere's Why Pieris Pharmaceuticals Inc. Is TankingShares drop after the company announces the pricing details of a common stock offering.
Feb 13, 2018 by Brian FeroldiHere's Why Henry Schein, Inc. Is Sinking TodayShares are tumbling after news breaks that the U.S. government has filed a lawsuit against the company.
Feb 11, 2018 by Brian Feroldi, Dan Caplinger, and Brian Stoffel3 Top Index Funds for Your IRADon't have time to pick your own stocks? These three funds have you covered.
Feb 11, 2018 by Brian Feroldi, Keith Speights, and Chuck Saletta3 Top Healthcare Stocks to Buy in FebruaryLooking for a few bargains in today's choppy market? Consider these three healthcare gems.
Feb 9, 2018 by Brian FeroldiWhy Pieris Pharmaceuticals Inc. Is Soaring TodayThe signing of a lucrative collaboration deal causes the share price to jump.
Feb 9, 2018 by Brian FeroldiInfinera Projects Optimism After Posting Solid ResultsThe optical equipment maker ends 2017 on a high note and sets the stage for growth in 2018.
Feb 8, 2018 by Brian FeroldiFormFactor's Revenue and Profits Rise but Guidance Indicates a Tough QuarterManagement expects that the current quarter is going to be challenging.
Feb 8, 2018 by Brian FeroldiWhy Lannett Company, Inc. Is Falling TodayShares tumbled after the generic-drug maker shared quarterly results that came up short of expectations.
Feb 8, 2018 by Brian FeroldiHere's Why Infinera Is Flying High TodayTraders cheer better-than-expected results and bullish guidance.
Feb 8, 2018 by Brian FeroldiHealthcare Services Group Earnings: Tax Reform Overshadows Strong Revenue GrowthNet income went into reverse due to recent changes to the tax code.
Feb 8, 2018 by Brian FeroldiHere's Why FormFactor, Inc. Is Falling TodayShares nosedive after management issues guidance that fails to impress.
Feb 7, 2018 by Brian FeroldiPaycom Software Guides for Strong Growth as Business Continues to BoomThe HR software company sees opportunity to take more market share.
Feb 6, 2018 by Brian FeroldiSkyworks Solutions Gives Investors Record Results, Boosted BuybackBusiness is booming for the semiconductor manufacturer.
